Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
5.56
-0.24 (-4.14%)
Apr 27, 2026, 3:19 PM EDT - Market open
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $6.29 million as of April 27, 2026. Its market cap has decreased by -80.02% in one year.
Market Cap
6.29M
Enterprise Value
2.11M
1-Year Change
-80.02%
Ranking
Category
Stock Price
$5.56
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $6.29M, a decrease of -97.84%. That is a compound annual growth rate of -30.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 6.56M | -50.39% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptorum Group | 7.31M |
| Acurx Pharmaceuticals | 7.27M |
| Immuron | 7.23M |
| Xenetic Biosciences | 6.99M |
| Can-Fite BioPharma | 6.95M |
| Alaunos Therapeutics | 6.56M |
| FibroBiologics | 6.45M |
| XTL Biopharmaceuticals | 6.33M |